NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

MRNA

Moderna Inc

May 08 • 04:00PM ET

24.38

Dollar change +0.32
Percentage change 1.33	%

Healthcare • Biotechnology • USA • NASD

Peers: BNTX NVAX REGN ALNY INCY BMRN SRPT VRTX GILD BIIB

| Held by: VTI VOO VB VO SPY IVV RSP XBI VBR XLV

Scroll to Statements

Index	S&P 500	P/E	-	EPS (ttm)	-8.72	Insider Own	11.45%	Shs Outstand	387.00M	Perf Week	-9.80%
Market Cap	9.43B	Forward P/E	-	EPS next Y	-7.51	Insider Trans	0.43%	Shs Float	342.48M	Perf Month	-1.06%
Income	-3357.00M	PEG	-	EPS next Q	-2.98	Inst Own	67.45%	Short Float	16.44%	Perf Quarter	-27.46%
Sales	3.18B	P/S	2.97	EPS this Y	-9.50%	Inst Trans	8.91%	Short Ratio	5.40	Perf Half Y	-54.46%
Book/sh	26.01	P/B	0.94	EPS next Y	26.07%	ROA	-22.81%	Short Interest	56.31M	Perf Year	-80.04%
Cash/sh	15.45	P/C	1.58	EPS next 5Y	20.33%	ROE	-29.34%	52W Range	23.15 - 170.47	Perf YTD	-41.37%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-42.94%	ROI	-31.18%	52W High	-85.70%	Beta	1.93
Dividend TTM	-	Quick Ratio	4.14	Sales past 5Y	662.63%	Gross Margin	48.06%	52W Low	5.31%	ATR (14)	1.78
Dividend Ex-Date	-	Current Ratio	4.22	EPS Y/Y TTM	44.29%	Oper. Margin	-117.37%	RSI (14)	38.42	Volatility	6.23% 6.25%
Employees	5800	Debt/Eq	0.07	Sales Y/Y TTM	-38.25%	Profit Margin	-105.67%	Recom	2.83	Target Price	44.81
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	18.22%	Payout	-	Rel Volume	0.93	Prev Close	24.06
Sales Surprise	1.71%	EPS Surprise	19.13%	Sales Q/Q	-35.33%	Earnings	May 01 BMO	Avg Volume	10.42M	Price	24.38
SMA20	-7.09%	SMA50	-16.91%	SMA200	-51.11%	Trades		Volume	9,668,982	Change	1.33%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60

Show Previous Ratings

May-08-25 07:00AM	Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025 (ACCESSWIRE)
May-07-25 07:17PM	Tracking Baillie Gifford's 13F Portfolio - Q1 2025 Update (Seeking Alpha)
11:00AM	Moderna study shows immune response in older adults for a combo flu and COVID-19 shot (Associated Press Finance)
09:26AM	Stock Market News for May 7, 2025 (Zacks)
07:26AM	VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations (Zacks)
10:12PM	Loading…
May-06-25 10:12PM	Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development (PR Newswire) -12.25%
04:49PM	S&P 500 Gains & Losses Today: Stocks Fall for Second Day as Palantir, Pharmaceuticals Drop (Investopedia)
02:04PM	Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator (Barrons.com)
09:54AM	Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1 (Zacks)
May-05-25 12:40AM	3 Cash-Heavy Stocks in the Doghouse (StockStory)
May-03-25 06:47AM	What Moved Markets This Week (Seeking Alpha)
May-02-25 09:30AM	Moderna (MRNA) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
03:03AM	Moderna Inc (MRNA) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Cost ... (GuruFocus.com)
12:21AM	Q1 2025 Moderna Inc Earnings Call (Thomson Reuters StreetEvents)
May-01-25 03:18PM	Moderna Cuts Costs as COVID Sales Slump (GuruFocus.com) -5.29%
01:30PM	Loading…
01:30PM	Moderna: Regulatory Hurdles And Market Challenges Prompt Downgrade To Sell (Seeking Alpha)
12:38PM	Moderna combination flu, COVID shot delayed amid FDA scrutiny (BioPharma Dive)
12:01PM	Moderna, Inc. (MRNA) Q1 2025 Earnings Call Transcript (Seeking Alpha)
11:26AM	Moderna Shares Drop As Political Picture Worsens (Barrons.com)
11:22AM	Moderna Beats on Q1 Earnings, Lags on Revenues, Focuses on Cost Cuts (Zacks)
11:20AM	Wayfair beats, Estee Lauder outlook, Moderna: Trending Tickers (Yahoo Finance Video)
09:37AM	Analyst Report: Moderna, Inc. (Morningstar Research)
09:10AM	Moderna Stock Crumbles As Vaccine Troubles Rattle Its Topline (Investor's Business Daily)
08:30AM	Moderna Stock Slips After Earnings Report. Guidance Was a Silving Lining. (Barrons.com)
07:40AM	Moderna (MRNA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
06:38AM	Moderna Posts Loss, Citing Seasonality of Respiratory Business (The Wall Street Journal)
06:37AM	Moderna: Q1 Earnings Snapshot (Associated Press Finance)
06:33AM	Moderna beats Wall Street estimates for first-quarter profit and sales (Reuters)
06:30AM	Moderna Misses Sales Forecasts, But Maintains Full-Year Outlook (Investor's Business Daily)
06:30AM	Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates (ACCESSWIRE)
07:41PM	Loading…
Apr-30-25 07:41PM	Moderna, Inc. (MRNA): Among the Worst Performing Stocks in S&P 500 So Far in 2025 (Insider Monkey)
04:38PM	Moderna Earnings Are Up Next. A Worsening Political Environment Adds to a Tough Year. (Barrons.com)
Apr-29-25 10:01AM	Analysts Estimate Pacira (PCRX) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:00AM	Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics (PR Newswire)
Apr-28-25 09:16AM	Countdown to Moderna (MRNA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
07:48AM	Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat? (Zacks)
06:21AM	Down 36%, Is Moderna a Buy on the Dip? (Motley Fool)
Apr-26-25 09:30AM	Market Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and Hold (Motley Fool)
Apr-25-25 05:50PM	Moderna (MRNA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
11:57AM	Can Moderna Keep the Beat Streak Alive This Earnings Season? (Zacks)
Apr-24-25 01:50PM	Is Moderna Stock A Sell After Massive Job Cuts Wrack U.S. Health Agencies? (Investor's Business Daily)
10:01AM	Moderna (MRNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
09:02AM	3 Healthcare Stocks Facing Headwinds (StockStory)
06:00AM	Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare (PR Newswire)
03:18AM	Flagships latest venture reflects more than 25 years of leaping into the unknown (Pharma Voice)
Apr-23-25 02:50PM	Why vaccine makers aren't worried about Trump administration cuts (Yahoo Finance)
Apr-22-25 12:58PM	More Downside For Moderna Before The Breakthrough (Seeking Alpha)
Apr-21-25 04:05PM	Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders (Business Wire)
Apr-20-25 03:10PM	Where Will Moderna Be in 5 Years? (Motley Fool)
Apr-17-25 05:50PM	Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
03:31PM	US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years (Benzinga)
10:51AM	Vaccine Stocks Rise on Growing Threat of Bird Flu Infections (Zacks)
09:20AM	GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59 (Zacks)
Apr-14-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Apr-11-25 11:33AM	NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 Jab (Zacks) +6.94%
11:20AM	Novavax slides after RFK Jr. casts doubts about COVID vaccine (TipRanks)
08:39AM	Novavax: Regulatory Uncertainty Creates Risk And Opportunity For Beaten-Down Vaccine Developer (Seeking Alpha)
Apr-10-25 12:01PM	Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks. (Investor's Business Daily) -8.14%
07:00AM	Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 (ACCESSWIRE)
Apr-08-25 07:25PM	Why Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022 (Motley Fool) +8.24%
02:09PM	Is Moderna, Inc. (MRNA) the Best Long Term Growth Stock to Buy According to Billionaires? (Insider Monkey)
06:55AM	VRTX Secures Nod for Expanded Use of CF Drug Kaftrio in Europe (Zacks)
Apr-07-25 07:00AM	Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025 (ACCESSWIRE)
Apr-05-25 06:34PM	Jim Cramer Calls Moderna (MRNA) 'Problematic' (Insider Monkey)
Apr-04-25 01:00AM	11 Stocks to Buy After the Biotech Bloodbath (Barrons.com)
Apr-03-25 09:05PM	Analyst Report: Moderna, Inc. (Morningstar Research) -7.18%
03:39PM	FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS (Yahoo Finance)
08:30AM	Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna (Motley Fool)
06:20AM	Is Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) a Strong ETF Right Now? (Zacks)
04:08AM	FDA News Just Shook Moderna. Is the Stock One to Avoid or a Bad-News Buy? (Motley Fool)
Apr-02-25 12:43PM	Potential Stock Woe Ahead as Pfizer (PFE) Riles Donald Trump (TipRanks)
07:37AM	PFE Secures EU Nod for Expanded Use of RSV Vaccine Abrysvo (Zacks)
Apr-01-25 12:42PM	Is Moderna, Inc. (MRNA) the Best Gene-Editing Stock to Buy? (Insider Monkey)
12:15PM	3 Market Predictions For April (Seeking Alpha)
11:50AM	Biotech stocks slide as Marks resignation seen being negative for sector (TipRanks)
08:00AM	Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease (PR Newswire)
07:45AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:23AM	Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr. (Zacks)
Mar-31-25 10:29PM	Watch These Moderna Price Levels as Stock Sinks to 5-Year Low (Investopedia) -8.90%
05:15PM	FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) (Seeking Alpha)
04:40PM	S&P 500 Gains and Losses Today: Moderna Stock Plunges After Resignation of FDA Vaccine Official (Investopedia)
04:13PM	Moderna (MRNA) Stock Trades Down, Here Is Why (StockStory)
04:12PM	Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies' (Investor's Business Daily)
01:58PM	Why Moderna Stock Is Plummeting Today (Motley Fool)
01:07PM	Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says wishes subservient confirmation of his misinformation and lies (Fortune)
12:26PM	Moderna, Rocket, Hut 8: Market Minute (Yahoo Finance Video)
12:01PM	Top Stock Movers Now: Tesla, Nvidia, Moderna, and More (Investopedia)
11:52AM	Moderna Stock Falls as FDA Vaccine Chief Resigns, Citing RFK Jr.'s 'Misinformation' (Investopedia)
11:10AM	Stocks to Watch Monday: Mr. Cooper, Nvidia, Newsmax, Moderna (The Wall Street Journal)
10:39AM	Moderna and other vaccines stocks are down after the FDA's top vaccine official resigns (Quartz)
09:57AM	Moderna, biotech stocks slide on resignation of FDA official Peter Marks (Yahoo Finance)
09:57AM	Moderna, biotech stocks slide following resignation of FDA official Peter Marks (Yahoo Finance)
09:45AM	Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns (Investor's Business Daily)
09:44AM	Moderna shares drop amid FDA leadership change (Yahoo Finance Video)
09:40AM	Stocks to Watch Monday: Nvidia, Tesla, Moderna, Robinhood (The Wall Street Journal)
09:31AM	Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out (The Wall Street Journal)
07:00AM	Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults (ACCESSWIRE)
Mar-29-25 04:17PM	Jim Cramer Slams Moderna, Inc. (MRNA) as One of the Year's Biggest Disappointments (Insider Monkey)
Mar-28-25 04:00PM	China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market (Investor's Business Daily) -8.90%
09:48AM	Arbutus Biopharma: A Wing And A Prayer (Seeking Alpha)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bancel Stephane	Chief Executive Officer	Mar 03 '25	Buy	31.22	160,314	5,004,318	9,210,686	Mar 04 04:27 PM
SAGAN PAUL	Director	Mar 03 '25	Buy	31.76	31,620	1,004,251	312,027	Mar 04 04:24 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 09 '24	Sale	44.68	529	23,637	20,446	Dec 10 04:08 PM
Klinger Shannon Thyme	Officer	Dec 09 '24	Proposed Sale	44.68	529	23,637		Dec 09 03:18 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 03 '24	Sale	43.30	112	4,849	19,837	Dec 04 05:11 PM
Hoge Stephen	President	Dec 03 '24	Sale	43.30	314	13,595	1,443,904	Dec 04 05:08 PM
Klinger Shannon Thyme	Officer	Dec 03 '24	Proposed Sale	43.30	112	4,849		Dec 03 04:11 PM
Hoge Stephen	Officer	Dec 03 '24	Proposed Sale	43.30	314	13,595		Dec 03 03:23 PM
Mock James M	Chief Financial Officer	Nov 29 '24	Sale	42.79	1,420	60,761	11,066	Dec 02 04:26 PM
Klinger Shannon Thyme	Chief Legal Officer	Nov 29 '24	Sale	42.79	1,418	60,675	19,717	Dec 02 04:19 PM
Hoge Stephen	President	Nov 29 '24	Sale	42.79	291	12,452	1,443,567	Dec 02 04:15 PM
Hoge Stephen	Officer	Nov 29 '24	Proposed Sale	42.79	291	12,452		Nov 29 03:54 PM
Klinger Shannon Thyme	Officer	Nov 29 '24	Proposed Sale	42.79	1,418	60,675		Nov 29 03:49 PM
Mock James M	Officer	Nov 29 '24	Proposed Sale	42.79	1,420	60,761		Nov 29 03:35 PM
Hoge Stephen	President	Nov 11 '24	Sale	46.10	277	12,771	1,443,248	Nov 12 04:14 PM
Hoge Stephen	Officer	Nov 11 '24	Proposed Sale	46.10	277	12,771		Nov 12 09:27 AM
Mock James M	Chief Financial Officer	Oct 07 '24	Sale	60.12	715	42,986	9,505	Oct 08 04:19 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 09 '24	Sale	73.57	551	40,539	18,154	Sep 10 04:15 PM
Klinger Shannon Thyme	Officer	Sep 09 '24	Proposed Sale	73.57	551	40,539		Sep 09 03:29 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 03 '24	Sale	76.99	114	8,777	17,566	Sep 04 05:42 PM
Hoge Stephen	President	Sep 03 '24	Sale	76.99	318	24,483	1,443,002	Sep 04 04:26 PM
Klinger Shannon Thyme	Officer	Sep 03 '24	Proposed Sale	76.99	114	8,777		Sep 03 03:58 PM
Hoge Stephen	Officer	Sep 03 '24	Proposed Sale	76.99	318	24,482		Sep 03 03:42 PM
Mock James M	Chief Financial Officer	Aug 29 '24	Sale	78.03	162	12,640	8,767	Aug 30 04:37 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 29 '24	Sale	78.03	162	12,640	17,447	Aug 30 04:34 PM
Hoge Stephen	President	Aug 29 '24	Sale	78.03	300	23,408	1,442,668	Aug 30 04:32 PM
Mock James M	Chief Financial Officer	Aug 28 '24	Sale	79.39	1,321	104,881	8,600	Aug 29 04:45 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 28 '24	Sale	79.39	1,319	104,722	17,280	Aug 29 04:03 PM
Klinger Shannon Thyme	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:52 PM
Mock James M	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:43 PM
Hoge Stephen	Officer	Aug 29 '24	Proposed Sale	78.03	300	23,408		Aug 29 03:38 PM
Mock James M	Officer	Aug 28 '24	Proposed Sale	79.39	1,321	104,881		Aug 28 04:47 PM
Klinger Shannon Thyme	Officer	Aug 28 '24	Proposed Sale	79.39	1,319	104,722		Aug 28 04:30 PM
Hoge Stephen	President	Aug 12 '24	Sale	84.10	254	21,363	1,442,357	Aug 13 04:33 PM
Hoge Stephen	Officer	Aug 12 '24	Proposed Sale	84.10	254	21,363		Aug 12 04:05 PM
AFEYAN NOUBAR	Director	Jul 31 '24	Sale	119.96	15,000	1,799,443	2,224,015	Aug 02 07:00 PM
NOUBAR B AFEYAN	Director	Jul 31 '24	Proposed Sale	118.84	15,000	1,782,600		Jul 31 04:18 PM
AFEYAN NOUBAR	Director	Jul 24 '24	Sale	117.80	15,000	1,766,972	2,239,015	Jul 26 07:00 PM
AFEYAN NOUBAR	Director	Jul 17 '24	Sale	122.84	15,000	1,842,651	2,254,015	Jul 19 07:00 PM
Hoge Stephen	President	Jul 15 '24	Sale	121.12	15,000	1,816,800	1,442,089	Jul 16 04:08 PM
AFEYAN NOUBAR	Director	Jul 10 '24	Sale	117.08	15,000	1,756,177	2,269,015	Jul 12 07:00 PM
Mock James M	Chief Financial Officer	Jul 08 '24	Sale	118.24	689	81,465	7,269	Jul 09 04:34 PM
AFEYAN NOUBAR	Director	Jun 26 '24	Sale	127.22	15,000	1,908,293	2,284,015	Jun 28 07:00 PM
AFEYAN NOUBAR	Director	Jun 18 '24	Sale	133.57	15,000	2,003,561	2,299,015	Jun 21 07:00 PM
Hoge Stephen	President	Jun 17 '24	Sale	138.16	15,000	2,072,400	1,457,089	Jun 18 04:05 PM
AFEYAN NOUBAR	Director	Jun 12 '24	Sale	147.20	15,000	2,208,071	2,314,015	Jun 14 07:00 PM
AFEYAN NOUBAR	Director	Jun 11 '24	Sale	148.34	202,832	30,087,339	1,528,557	Jun 11 07:01 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 10 '24	Sale	148.09	5,178	766,785	15,947	Jun 11 04:05 PM
AFEYAN NOUBAR	Director	Jun 05 '24	Sale	151.25	15,000	2,268,804	1,946,931	Jun 07 07:00 PM
Mock James M	Chief Financial Officer	Jun 03 '24	Sale	140.72	691	97,237	6,506	Jun 04 05:27 PM
Hoge Stephen	President	Jun 03 '24	Sale	140.72	339	47,704	1,472,089	Jun 04 05:20 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 03 '24	Sale	140.72	122	17,168	10,878	Jun 04 05:12 PM
AFEYAN NOUBAR	Director	May 29 '24	Sale	145.08	20,000	2,901,585	1,961,931	May 31 07:00 PM
Mock James M	Chief Financial Officer	May 29 '24	Sale	144.50	183	26,444	5,871	May 30 04:36 PM
Klinger Shannon Thyme	Chief Legal Officer	May 29 '24	Sale	144.50	183	26,444	10,768	May 30 04:27 PM
Hoge Stephen	President	May 29 '24	Sale	144.50	341	49,276	1,471,777	May 30 04:14 PM
Mock James M	Chief Financial Officer	May 28 '24	Sale	162.47	648	105,283	5,726	May 29 04:16 PM
Klinger Shannon Thyme	Chief Legal Officer	May 28 '24	Sale	162.47	1,296	210,566	10,623	May 29 04:12 PM
AFEYAN NOUBAR	Director	May 22 '24	Sale	157.57	15,000	2,363,556	1,981,931	May 24 07:00 PM
AFEYAN NOUBAR	Director	May 15 '24	Sale	127.32	15,000	1,909,863	1,996,931	May 17 07:00 PM
Hoge Stephen	President	May 15 '24	Sale	127.49	15,000	1,912,350	1,471,508	May 17 04:04 PM
Hoge Stephen	President	May 10 '24	Sale	120.96	255	30,844	1,486,508	May 13 04:03 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your FINVIZ experience